Osaic Holdings’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,890
Closed -$77.4K 8173
2025
Q3
$77.4K Buy
23,890
+738
+3% +$2.35K ﹤0.01% 4992
2025
Q2
$55.1K Sell
23,152
-3,000
-11% -$7.35K ﹤0.01% 4979
2025
Q1
$37.7K Sell
26,152
-136,988
-84% -$229K ﹤0.01% 4919
2024
Q4
$297K Buy
163,140
+17,886
+12% +$24.3K ﹤0.01% 3241
2024
Q3
$182K Buy
145,254
+375
+0.3% +$508 ﹤0.01% 3729
2024
Q2
$203K Hold
144,879
﹤0.01% 3547
2024
Q1
$239K Buy
144,879
+16,825
+13% +$27K ﹤0.01% 3537
2023
Q4
$207K Sell
128,054
-96,861
-43% -$146K ﹤0.01% 3896
2023
Q3
$484K Buy
+224,915
New +$481K ﹤0.01% 3266

Osaic Holdings's THTX Position: Q4 2025 in Review

Osaic Holdings sold out of Theratechnologies (THTX) in Q4 2025, closing a stake of 23,890 shares — an estimated $77.4K sold.

Osaic Holdings first reported a position in THTX in Q3 2023 and held it in 9 quarters. The position peaked at $484K in Q3 2023. 0 funds tracked by Wall St. Rank hold THTX as of Q4 2025.

  • Osaic Holdings reported no remaining Theratechnologies position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 23,890 Theratechnologies shares in Q4 2025, an estimated $77.4K.
  • Osaic Holdings first reported a position in Theratechnologies in Q3 2023 and held it in 9 quarters.
  • Osaic Holdings's Theratechnologies position peaked at $484K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.